Relief of Chronic Pain Act of 2025

S 3064, the Relief of Chronic Pain Act of 2025, modifies Medicare Part D coverage to improve access to non-opioid treatments for specific chronic pain conditions. It requires Medicare plans to exempt qualifying non-opioid drugs (approved for conditions like diabetic neuropathy, fibromyalgia, or musculoskeletal pain) from deductibles and place them on the lowest cost-sharing tier starting in 2026. The bill also bans step therapy (requiring opioid use first) and prior authorization for these drugs. This directly affects Medicare beneficiaries with the listed chronic pain conditions who rely on these approved non-opioid medications.